Year: 2020

The personal finance personality says you have to face COVID-19 as a financial warrior. …read more […]

(Bloomberg) — President Donald Trump said he’s sending federal emergency workers to Midland, Michigan, where dam failures have flooded a Dow Inc. chemical complex and homes in a disaster that may force the evacuation of more than 10,000 people.After two days of heavy rainfall, water from Lake Wixom breached one dam yesterday evening and then another late at night. That has caused Dow to close its headquarters and the manufacturing complex while the county has evacuated 1,000 people. As water levels continue to rise, the City of Midland expects to evacuate 10,000 more.In his tweeted response, Trump used the moment …read more […]

(Bloomberg) — The global plunge in electricity demand will drag on long after nations lift stay-at-home orders, leading to the biggest annual drop since the Great Depression and fundamentally reshaping power markets.As economies struggle to recover, worldwide electricity consumption will decline 5% in 2020, the most in more than eight decades, according to the International Energy Agency. In the U.S. last week, government analysts projected the nation’s biggest drop on record. And in Europe, analysts say a full recovery could take years.The prolonged slowdown will increase economic pressure on older, uneconomic power plants — especially those that burn coal — …read more […]

…read more […]

Ally Invest is a low-cost stock broker that’s challenging its competitors in attracting new investors. In fact, its signups are growing at a pace unlike ever before.
Ally’s first quarter results for 2020 are proof that it’s ready to take on Fidelity and others in the industry. Yet, many people are unfamiliar with the platform. Learn more about this thriving online broker below.

What is Ally Invest?
Ally Invest is a branch of Ally Financial (NYSE: ALLY) that provides automated investing with commission-free trading. Its appeal is that it suits both ends of the investing spectrum. Whether you are new to the stock …read more […]

Scientists are raising questions about Moderna’s COVID-19 vaccine trial and results, as the company has yet to reveal data that supports how its drug is successfully producing antibodies in human trials. Yahoo Finance’s Anjalee Khemlani joins the On the Move panel to discuss. …read more […]

Royal Caribbean Cruises Ltd, the world’s second largest cruise company, reported its first quarter earnings on Wednesday, sustaining a wider loss than analysts expected and delaying a return to sailing for a third time. The cruise line reported a net loss of $1.4 billion, or $6.91 per share, compared to $249.7 million net income and […] …read more […]

With unemployment rising to 15%, and the grim corporate earnings seasons wrapping up, investors may struggle to keep up the relatively buoyant mood that has boosted markets in recent weeks. Writing from JPMorgan, global market strategist Samantha Azzarello has commented on the apparent performance disconnect between the markets and the economy. “I think the volatility right now is tied to a bunch of different things whether we’re going up or going down — right it’s vaccine news, it’s treatment news, it’s Jay Powell speaking… I still think though there’s a little bit of a disconnect between the real side of …read more […]

Inovio Pharmaceuticals (INO) surged almost 10% after the company said that preclinical study data results of its potential vaccine candidate showed “robust” neutralizing antibody and T cell immune responses against coronavirus.Shares rose 9.5% to $15.94 in midday U.S. trading. The value of the stock has this year gone up five-fold with investors excited about Inovio’s potential Covid-19 vaccine INO-4800. The vaccine drug candidate targets the major antigen Spike protein of SARS-CoV-2 virus, which causes Covid-19 disease.”These positive preclinical results from our Covid-19 DNA vaccine not only highlight the potency of our DNA medicines platform, but also build on our previously …read more […]